BAGSVAERD, DENMARK--(Marketwire - August 11, 2011) -
In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons as reported by those persons to Novo Nordisk.
Company Announcement no 52 2011: http://hugin.info/2013/R/1537859/469644.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1537859]
Further information:
Media:
Anne Margrethe Hauge
Tel: (+45) 4442 3450
Email Contact
In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact
Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact